pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
553731d7-b6b8-4798-a852-493fff671761
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-18 19:56:32
Income (reported)
$50,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

FORBES-TATE

Government Relations Firm.

Contact
ZACHARY WILLIAMS
Phone
+1 202-638-0125
Address
zip:20001, city:Washington, state:DC, street:777 6th Street NW 8th Floor

Client

NOVARTIS, INC.

Multinational biopharmaceutical company

State
DC
Country
US
Government-entity client
false
Effective date
2019-03-26

Issues lobbied + lobbyists

TAX — Taxation/Internal Revenue Code

Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.

Lobbyists: DERRICK M WHITE; JEFFREY FORBES; ELIZABETH GREER; CYNTHIA BROWN; KRISTINA DUNKLIN; BARRETT THORNHILL; JEFFREY STRUNK; mr MICHAEL ALEXANDER WILLIAMS

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnostic Act of 2025.

Lobbyists: DERRICK M WHITE; JEFFREY FORBES; ELIZABETH GREER; CYNTHIA BROWN; KRISTINA DUNKLIN; BARRETT THORNHILL; JEFFREY STRUNK; mr MICHAEL ALEXANDER WILLIAMS

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.

Lobbyists: DERRICK M WHITE; JEFFREY FORBES; ELIZABETH GREER; CYNTHIA BROWN; KRISTINA DUNKLIN; BARRETT THORNHILL; JEFFREY STRUNK; mr MICHAEL ALEXANDER WILLIAMS

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TRD — Trade (domestic/foreign)

Issues related to prescription drug pricing; Issues related to pharmaceutical intellectual property; Issues related to international trade; Issues related to the 340b program.

Lobbyists: DERRICK M WHITE; JEFFREY FORBES; ELIZABETH GREER; CYNTHIA BROWN; KRISTINA DUNKLIN; BARRETT THORNHILL; JEFFREY STRUNK; mr MICHAEL ALEXANDER WILLIAMS

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

BUD — Budget/Appropriations

Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.

Lobbyists: DERRICK M WHITE; JEFFREY FORBES; ELIZABETH GREER; CYNTHIA BROWN; KRISTINA DUNKLIN; BARRETT THORNHILL; JEFFREY STRUNK; mr MICHAEL ALEXANDER WILLIAMS

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

CPT — Copyright/Patent/Trademark

Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the 340b program.

Lobbyists: DERRICK M WHITE; JEFFREY FORBES; ELIZABETH GREER; CYNTHIA BROWN; KRISTINA DUNKLIN; BARRETT THORNHILL; JEFFREY STRUNK; mr MICHAEL ALEXANDER WILLIAMS

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.